Clinical Trial Update: Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial updates for PR022 topical gel in mild-to-moderate atopic dermatitis focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PR022 topical gel

Snippet

Sponsor: Realm Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: UNKNOWN